Companies / Generare Bioscience
Generare Bioscience
Paris, France
Generare develops new medicines by exploring and utilizing microbial chemistry
Generare Bioscience, based in Paris, France, has 6 investors on file, among them Agoranov, Alven and daphni. Its latest round on record is Series A, 2 Apr 2026. Its site was last checked 12 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
6 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator | |
| Page + round | Venture capital | |
| Page + round | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Generare Bioscience and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Agoranov adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/generare.bio/investors
# also
GET /v1/companies/generare.bio
GET /v1/companies/generare.bio/news